Blood-brain barrier
“DAMPs such as HMG-1 bind to TLR4 and receptors for advanced glycation end products (RAGE) on cells at the blood-brain barrier to induce an immune response that initially inhibits the deposition of amyloid-beta, a key feature of Alzheimer's disease progression.”